SCHEMBL308777

SCHEMBL308777

NC(=O)NCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28213551 0.97 LMNA (0.36)
SCHEMBL19114273 0.84 LMNA (0.36)
SCHEMBL2778468 0.79 SMN1; SMN2 (0.35)
SCHEMBL4535690 0.79 TDP1 (0.34)
SCHEMBL30223288 0.79 CA3 (0.41)
SCHEMBL3917161 0.77 LMNA (0.37)
SCHEMBL9348376 0.77 SMN1; SMN2 (0.53)
SCHEMBL13504795 0.75 LOXL2 (0.36)
SCHEMBL193635 0.74
SCHEMBL967610 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392144-A1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA MERCK SHARP & DOHME CORP. (US) 2020-12-17 US claimed
EP-3727380-A1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA Merck Sharp&Dohme Corp. (US) 2020-10-28 EP claimed
EP-2872491-A2 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR Blueprint Medicines Corporation (US) 2015-05-20 EP claimed
CN-104540809-A Inhibitors of fibroblast growth factor receptors BLUEPRINT MEDICINES 2015-04-22 CN claimed
WO-2014011900-A2 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR BLUEPRINT MEDICINES (US) 2014-01-16 WO claimed
WO-2012088266-A2 SUBSTITUTED IMIDAZOPYRIDAZINES AND BENZIMIDAZOLES AS INHIBITORS OF FGFR3 INCYTE CORPORATION (US) 2012-06-28 WO claimed
US-20090104116-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2009-04-23 US claimed
EP-1979342-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF Jerini AG (DE) 2008-10-15 EP claimed
WO-2007088041-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2007-08-09 WO claimed
EP-1786809-A2 AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONISTS Sanofi-Aventis (FR) 2007-05-23 EP claimed
WO-2006021656-A2 AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONISTS SANOFI-AVENTIS (FR) 2006-03-02 WO claimed
EP-0610472-A1 STEROIDS WITH A FLUORINATED ACYLUREIDIC TYPE SIDE CHAIN PHARMACIA &amp; UPJOHN S.p.A. (IT) 1994-08-17 EP claimed
WO-1994003474-A1 STEROIDS WITH A FLUORINATED ACYLUREIDIC TYPE SIDE CHAIN PHARMACIA/FARMITALIA CARLO ERBA SRL (IT) 1994-02-17 WO claimed
WO-2025149498-A1 BENZYLPIPERIDINE DERIVATIVES AS TRP4 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2025-07-17 WO disclosed
WO-2025038698-A1 CRYSTALLINE FORMS OF A PI3K INHIBITOR AND USES OF SAME SCORPION THERAPEUTICS, INC. (US) 2025-02-20 WO disclosed
US-12152018-B2 Compounds and compositions for treating conditions associated with STING activity IFM DUE, INC. (US) 2024-11-26 US disclosed
EP-1250332-A1 INHIBITORS OF INTERLEUKIN 5 GENE EXPRESSION Abbott Laboratories (US) 2002-10-23 EP disclosed
WO-2001044223-A1 INHIBITORS OF INTERLEUKIN 5 GENE EXPRESSION ABBOTT LABORATORIES (US) 2001-06-21 WO disclosed
EP-0610472-A1 STEROIDS WITH A FLUORINATED ACYLUREIDIC TYPE SIDE CHAIN PHARMACIA &amp; UPJOHN S.p.A. (IT) 1994-08-17 EP disclosed
WO-1994003474-A1 STEROIDS WITH A FLUORINATED ACYLUREIDIC TYPE SIDE CHAIN PHARMACIA/FARMITALIA CARLO ERBA SRL (IT) 1994-02-17 WO disclosed